← 產業報告目錄
Contraceptive Market Size, Share & Trends Analysis Report By Product( Contraceptive Drugs(Contraceptive Pills, Patch, Injectables), Contraceptive Devices(Condoms(Male Condoms, Female Condoms), Subdermal Implants, IUDs(Copper IUDs, Hormonal IUDs), Vaginal Rings, Diaphragm), By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-17頁數 180報告編號 INSIGHTACE-e54b793c78
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 32.5 Billion, the global Contraceptive Market is poised to surge to USD 69.0 Billion by 2034, demonstrating a CAGR of 7.9% during the 2025–2034 forecast window.
Contraceptive encompasses The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Contraceptive Market Snapshot
Chapter 4. Global Contraceptive Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 -2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following by Product Type:
5.2.1. Contraceptive Drugs
5.2.1.1. Contraceptive Pills
5.2.1.2. Patch
5.2.1.3. Injectables
5.2.2. Contraceptive Devices
5.2.2.1. Condoms
5.2.2.1.1. Male Condoms
5.2.2.1.2. Female Condoms
5.2.2.2. Subdermal Implants
5.2.2.3. IUDs
5.2.2.3.1. Copper IUDs
5.2.2.3.2. Hormonal IUDs
5.2.2.4. Vaginal Rings
5.2.2.5. Diaphragm
Chapter 6. Contraceptive Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
6.1.2. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.2. Europe
6.2.1. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
6.2.2. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.3. Asia Pacific
6.3.1. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
6.3.2. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country,2021-2034
6.4. Latin America
6.4.1. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
6.4.2. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.5. Middle East & Africa
6.5.1. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
6.5.2. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Bayer AG
7.2.2. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
7.2.3. Cupid Ltd.
7.2.4. Helm AG
7.2.5. Church & Dwight
7.2.6. Organon Group Of Companies
7.2.7. Pfizer Inc.
7.2.8. Viatris (Mylan)
7.2.9. Abbvie, Inc.
7.2.10. Afaxys, Inc.
7.2.11. Veru, Inc.
7.2.12. Agile Therapeutics
7.2.13. Janssen Pharmaceuticals, Inc.
7.2.14. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們